The promoter-cloning plasmid pBRH4 (a derivative of pBR322 with a partially deleted promoter of the tet gene) is shown to contain a sequence which is located near the EcoRI site and can operate as an effective Pribnow box, but is not the remainder of the deletion-inactivated tet promoter of pBR322. If there is a sequence homologous to the ' -35' promoter region at the border of the DNA fragment inserted at the EcoRI site, then a compound promoter arises and activates the tet gene. Point mutations in the nonfunctional -35 region of pBRH4 also activate the cryptic Pribnow box. Several compound promoters were obtained through deleting small portions of DNA around the Hind111 site of pBR322; the deletions moved various sequences that could operate as Pribnow boxes towards the -35 region of the tet promoter.
INTRODUCTION
Several plasmids with a partially deleted promoter of the tetracycline resistance gene have been used for promoter cloning [l-3] . It has already been noted that the activation of the tet gene does not always indicate the presence of the natural promoter in the inserted fragment but may reflect an incidental fit of the end of the fragment and the remainder of the tet gene promoter giving rise to a compound promoter [3] . This property of the pBRH4 plasmid, which makes it an imperfect vector for promoter cloning, has been used here to generate artificial promoters.
MATERIALS AND METHODS
Plasmids were isolated as in [4] . DNA was sequenced as in [5] as modified in [6] . Deletions in pBR322 were obtained through treatment of a HindIII-linearized plasmid (2 pg) with 5 units Sl nuclease in 100 ~1 of 100 mM NaCl, 3 mM ZnS04, 30 mM sodium acetate (pH 4.8) for lo-30 min at 20°C. The resulting DNA after blunt-end ligation was used to transform E. coli HBlOl cells, then ampicillin resistant clones were selected and tested for tetracycline resistance.
Mutations that activate the tet gene were obtained either by selecting spontaneously arising TetR clones of E. coli C600 (pBRH4) or through treatment of these cells with 10 pg/ml N-nitro-N'-nitrosoguanidine.
The MspI fragment of pBR322, which contains the tet gene promoter, was used for the S 1 -mapping of transcription starting points. The fragment was labelled at the 5 '-end with T4 polynucleotide kinase [5], cleaved with BspRI, then the large subfragment was isolated. RNA extraction and Sl mapping were carried out as in [7] with the following modifications: during Sl treatment NaCl was added to 500 mM, the duration of treatment was reduced to 5 min and the temperature was 20°C.
RESULTS AND DISCUSSION
The plasmid pEG3503, obtained earlier through inserting the EcoRI-G fragment of the rpoBC operon into pBRH4 [8] , makes cells resistant to 20 pg/ml tetracycline despite the fact that the pro- in the EcoRI-G fragment was reported to be weak [9, lo] . To localize the promoter that caused tetracycline resistance, the transcription initiation point was determined by the Sl mapping experiments. The transcription of the tet gene in pEG3503 containing cells was shown to be initiated near the border of pBRH4 and the inserted fragment (see fig.l ,2). One can see that the Pribnow box, which does not coincide with the Pribnow box of the pBR322 tet promoter, belongs to pBRH4, and the -35 region belongs to the fragment of the rpoBC operon which normally encodes Fig.1 . Sl-mapping of 5'-ends of plasmid transcripts: 1, pBRA22; 2, pBRA15; 3, pBR322; 6, pBIU10; 7, pEG3503; 8, pBRH4-25; 4,5, DNA fragments obtained as in [5] and used as M, markers.
the amino acids of the P-subunit of RNA polymerase.
The tet gene does not work in pBRH4 without the insertion, even though there is a Pribnow box, i.e., the sequence occupying the -35 position is not functional. However, pBRH4 gives rise to mutants which sustain cell growth on 20pg/ml tetracycline with a spontaneous frequency of lo-' and a nitrosoguanidine-induced frequency of 10-5-10-4. The Sl mapping of 1 spontaneous and 6 nitrosoguanidine-induced mutant variants of pBRH4 ( fig.1 shows the data for one of them) revealed one starting point in all cases, the same as in pEG3503, i.e., the same Pribnow box as in the above described compound promoter operates here. One of the nitrosoguanidine-induced pBRH4 mutants (pBRH4-25) has been sequenced. As shown in fig.2 , the mutation substitutes T for C at position -34 from the starting point, i.e., creates a functional -35 region.
These results show that when there is a readymade Pribnow box it is easy enough to select a sequence that will function as a -35 region. That is what happened in the case of pEG3503 and, presumably, in other cases when artifacts were observed during cloning in pBRH4. A similar situation may be expected to arise when there is a ready-made -35 region and various sequences are fitted to it. To test this supposition, we obtained several deletion derivatives of pBR322 with an 'ideal' sequence in the -35 region of the tet promoter. Deletions were obtained in the vicinity of the Hind111 site (see section 2). After transformap'EC,35"3 TC~CTCCACTTCCAhTTCA===-=~~~==~===~=~~======== pBrW-25 TTTCCTTTTCAACAATTT,~==--=--1--======F====~====== tion we selected 3 clones containing deleted plasmids and having different levels of tetracycline resistance. Plasmid sequences are shown in fig.2 . In accordance with the deletion length, they are denoted pBRA 10, pBRAl5 and pBRA22. The Sl mapping of these plasmids ( fig.1 ) has shown, as expected, that one and the same -35 region operates in all 3 cases and the promoters differ in their Pribnow boxes. The pBRd 10 plasmid, which has a stronger tet promoter than pBR322, proved to have the same transcription starting point, hence the same Pribnow box, as pEG3503 and the pBRH4 mutants with an activated tet gene. In pBRA15 and pBRA22 the tet promoter is not very effective, but at least in pBRA22 nitrosoguanidine induces mutations (approximate frequency IO-') which increase the promoter efficiency several times.
Our results show that a promoter arises with comparative ease if either of its 'halves' is already present. By fitting to it various DNA sequences to recreate a whole promoter one can, in principle, construct many artificial promoters. The process may also occur naturally. For example, it was in this way that a promoter appeared in the gal operon on the insertion of the IS2 element ]I 11.
Our data allow the efficiency and the sequence to be compared for 7 variants of the tet promoter: 4 promoters have the same -35 region but different Pribnow boxes (pBR322, pBM 10, pBRA 15 and pBRA22), and 4 variants have the same Pribnow box but different -35 sequences (pEG3503, pBRA 10, pBRH4 and pBRH4-25). Fig.3 shows the promoter sequences and summarizes the efficiency data. Promoter efficiency was evaluated by the level of tetracycline resistance of cells carrying the plasmid concerned and by the amount of nucleaseresistant DNA fragments in Sl mapping experiments (the two methods correlate quite well). The relation between the efficiency of these promoters and their sequence is discussed at length elsewhere. 
